Lapatinib Active Not Recruiting Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01283789Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer